Nanjing Iaso Biotherapeutics Co., Ltd
驯鹿生物
Nanjing Iaso Biotherapeutics Co., Ltd
Biotech/Healthcare
Reindeer Biotherapeutics (Xunlu Medical) focuses on the R&D, technical services, and clinical application of immune cell therapy technologies and other biopharmaceutical technologies, with a particular emphasis on chimeric antigen receptor T-cell (CAR-T) technology for hematological malignancies.…
Latest round: Series C (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-09-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.